A Community Based Approach for Tackling the Post-Genomic Data Deluge
News Oct 14, 2013
The article highlights BBSRC-funded research that uses publicly available data as a powerful, cost-effective approach to producing comprehensive parts lists of functional elements of genomes.
The research, conducted by Professor Bertie Göttgens at the University of Cambridge, created HAEMCODE, a repository for transcription factor binding maps in mouse blood cells.
Transcription factors are proteins that bind to specific DNA sequences, thereby controlling the flow of genetic information from DNA to messenger RNA. Mapping these transcription factors helps to build annotated genomes that relate structure to function.
This research gathered this vital data using a community approach. Professor Göttgens explains: "Instead of making advanced decisions about the datasets as large scale projects do, we have compiled datasets produced by the community, as soon as they are deposited in public databases."
"We manually curated more than 300 studies from a wide range of mouse cell line models to create a compendium that covered 84 transcription factors. Currently available data from large consortium projects covers less than half of this."
The HAEMCODE repository demonstrates that community annotation and real-time curation of datasets generated by individual research labs across the world is not only a powerful, but also a very cost-effective approach for expanding datasets available to researchers.
The researchers also developed a web interface HAEMCODE to provide data access as well as a range of online analysis tools, designed to be useful to both experimentalist and computational biologists.
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease RiskNews
Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.READ MORE
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE